Sandoz to Pay $265 Mln in U.S. to Solve Generic Drug Antitrust Litigation
By Mauro Orru Sandoz Group said its U.S. subsidiaries would pay $265 million to settle a generic pharmaceuticals pricing antitrust litigation. The maker of...
Source: marketwatch.com